최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Molecules and cells, v.43 no.1, 2020년, pp.23 - 33
Jang, Hanbit (Department of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST)) , Park, Seulki (Disease Target Structure Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB)) , Kim, Jaehoon (Department of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST)) , Kim, Jong Hwan (Personalized Genomic Medicine Research Center, KRIBB) , Kim, Seon-Young (Personalized Genomic Medicine Research Center, KRIBB) , Cho, Sayeon (College of Pharmacy, Chung-Ang University) , Park, Sung Goo (Disease Target Structure Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB)) , Park, Byoung Chul (Disease Target Structure Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB)) , Kim, Sunhong (Disease Target Structure Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB)) , Kim, Jeong-Hoon (Disease Target Structure Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB))
NF-κB signaling through both canonical and non-canonical pathways plays a central role in immune responses and inflammation. NF-κB-inducing kinase (NIK) stabilization is a key step in activation of the non-canonical pathway and its dysregulation implicated in various hematologic malign...
Balaji S. Ahmed M. Lorence E. Yan F. Nomie K. Wang M. 2018 NF-κB signaling and its relevance to the treatment of mantle cell lymphoma J Hematol Oncol 11 83 10.1186/s13045-018-0621-5 29907126
Bartel D.P. 2018 Metazoan MicroRNAs Cell 173 20 51 10.1016/j.cell.2018.03.006 29570994
Beg M.S. Brenner A.J. Sachdev J. Borad M. Kang Y.K. Stoudemire J. Smith S. Bader A.G. Kim S. Hong D.S. 2017 Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors Invest New Drugs 35 180 188 10.1007/s10637-016-0407-y 27917453
Benitez J.A. Ma J. D’Antonio M. Boyer A. Camargo M.F. Zanca C. Kelly S. Khodadadi-Jamayran A. Jameson N.M. Andersen M. 2017 PTEN regulates glioblastoma oncogenesis through chromatin-associated complexes of DAXX and histone H3.3 Nat Commun 8 15223 10.1038/ncomms15223 28497778
Chi S.W. Zang J.B. Mele A. Darnell R.B. 2009 Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps Nature 460 479 486 10.1038/nature08170 19536157
Choi J.S. Park B.C. Chi S.W. Bae K.H. Kim S. Cho S. Son W.C. Myung P.K. Kim J.H. Park S.G. 2014 HAX1 regulates E3 ubiquitin ligase activity of cIAPs by promoting their dimerization Oncotarget 5 10084 10099 10.18632/oncotarget.2459 25275296
Dice J.F. 2007 Chaperone-mediated autophagy Autophagy 3 295 299 10.4161/auto.4144 17404494
Forman J.J. Legesse-Miller A. Coller H.A. 2008 A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence Proc Natl Acad Sci U S A 105 14879 14884 10.1073/pnas.0803230105 18812516
Ha M. Kim V.N. 2014 Regulation of microRNA biogenesis Nat Rev Mol Cell Biol 15 509 524 10.1038/nrm3838 25027649
Hermeking H. 2010 The miR-34 family in cancer and apoptosis Cell Death Differ 17 193 199 10.1038/cdd.2009.56 19461653
Hermeking H. 2012 MicroRNAs in the p53 network: micromanagement of tumour suppression Nat Rev Cancer 12 613 626 10.1038/nrc3318 22898542
Huang W.C. Ju T.K. Hung M.C. Chen C.C. 2007 Phosphorylation of CBP by IKKalpha promotes cell growth by switching the binding preference of CBP from p53 to NF-kappaB Mol Cell 26 75 87 10.1016/j.molcel.2007.02.019 17434128
Jin Y. Chen Z. Liu X. Zhou X. 2013 Evaluating the microRNA targeting sites by luciferase reporter gene assay Methods Mol Biol 936 117 127 10.1007/978-1-62703-083-0_10 23007504
Kastenhuber E.R. Lowe S.W. 2017 Putting p53 in context Cell 170 1062 1078 10.1016/j.cell.2017.08.028 28886379
Kawauchi K. Araki K. Tobiume K. Tanaka N. 2009 Loss of p53 enhances catalytic activity of IKKbeta through O-linked beta-N-acetyl glucosamine modification Proc Natl Acad Sci U S A 106 3431 3436 10.1073/pnas.0813210106 19202066
Keats J.J. Fonseca R. Chesi M. Schop R. Baker A. Chng W.J. Van Wier S. Tiedemann R. Shi C.X. Sebag M. 2007 Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma Cancer Cell 12 131 144 10.1016/j.ccr.2007.07.003 17692805
Kendellen M.F. Bradford J.W. Lawrence C.L. Clark K.S. Baldwin A.S. 2014 Canonical and non-canonical NF-κB signaling promotes breast cancer tumor-initiating cells Oncogene 33 1297 1305 10.1038/onc.2013.64 23474754
Kim J.S. Kim E.J. Lee S. Tan X. Liu X. Park S. Kang K. Yoon J.S. Ko Y.H. Kurie J.M. 2019 MiR-34a and miR-34b/c have distinct effects on the suppression of lung adenocarcinomas Exp Mol Med 51 9 10.1038/s12276-018-0203-1 30700696
Kim N.H. Kim H.S. Kim N.G. Lee I. Choi H.S. Li X.Y. Kang S.E. Cha S.Y. Ryu J.K. Na J.M. 2011 p53 and microRNA-34 are suppressors of canonical Wnt signaling Sci. Signal 4 ra71 10.1126/scisignal.2001744 22045851
Leucci E. Cocco M. Onnis A. De Falco G. van Cleef P. Bellan C. van Rijk A. Nyagol J. Byakika B. Lazzi S. 2008 MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation J Pathol 216 440 450 10.1002/path.2410 18802929
Lin J. Chen J. Elenbaas B. Levine A.J. 1994 Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein Genes Dev 8 1235 1246 10.1101/gad.8.10.1235 7926727
Lin X. Mu Y. Cunningham E.T. Jr Marcu K.B. Geleziunas R. Greene W.C. 1998 Molecular determinants of NF-kappaB-inducing kinase action Mol Cell Biol 18 5899 5907 10.1128/MCB.18.10.5899 9742107
Mayo M.W. Madrid L.V. Westerheide S.D. Jones D.R. Yuan X.J. Baldwin A.S. Jr Whang Y.E. 2002 PTEN blocks tumor necrosis factor-induced NF-kappa B-dependent transcription by inhibiting the transactivation potential of the p65 subunit J Biol Chem 277 11116 11125 10.1074/jbc.M108670200 11799112
O’Keefe K. Li H. Zhang Y. 2003 Nucleocytoplasmic shuttling of p53 is essential for MDM2-mediated cytoplasmic degradation but not ubiquitination Mol Cell Biol 23 6396 6405 10.1128/MCB.23.18.6396-6405.2003 12944468
Onder T.T. Gupta P.B. Mani S.A. Yang J. Lander E.S. Weinberg R.A. 2008 Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways Cancer Res 68 3645 3654 10.1158/0008-5472.CAN-07-2938 18483246
Otto C. Giefing M. Massow A. Vater I. Gesk S. Schlesner M. Richter J. Klapper W. Hansmann M.L. Siebert R. 2012 Genetic lesions of the TRAF3 and MAP3K14 genes in classical Hodgkin lymphoma Br J Haematol 157 702 708 10.1111/j.1365-2141.2012.09113.x 22469134
Pigazzi M. Manara E. Baron E. Basso G. 2009 miR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia Cancer Res 69 2471 2478 10.1158/0008-5472.CAN-08-3404 19258499
Rahal R. Frick M. Romero R. Korn J.M. Kridel R. Chan F.C. Meissner B. Bhang H.E. Ruddy D. Kauffmann A. 2014 Pharmacological and genomic profiling identifies NF-κB-targeted treatment strategies for mantle cell lymphoma Nat Med 20 87 92 10.1038/nm.3435 24362935
Ravi R. Mookerjee B. van Hensbergen Y. Bedi G.C. Giordano A. El-Deiry W.S. Fuchs E.J. Bedi A. 1998 p53-mediated repression of nuclear factor-kappaB RelA via the transcriptional integrator p300 Cancer Res 58 4531 4536 9788595
Rocha S. Campbell K.J. Perkins N.D. 2003 p53- and Mdm2-independent repression of NF-kappa B transactivation by the ARF tumor suppressor Mol Cell 12 15 25 10.1016/S1097-2765(03)00223-5 12887889
Slabakova E. Culig Z. Remsik J. Soucek K. 2017 Alternative mechanisms of miR-34a regulation in cancer Cell Death Dis 8 e3100 10.1038/cddis.2017.495 29022903
Sullivan K.D. Galbraith M.D. Andrysik Z. Espinosa J.M. 2018 Mechanisms of transcriptional regulation by p53 Cell Death Differ 25 133 143 10.1038/cdd.2017.174 31745311
Sun S.C. 2017 The non-canonical NF-κB pathway in immunity and inflammation Nat Rev Immunol 17 545 558 10.1038/nri.2017.52 28580957
Suzuki H.I. Yamagata K. Sugimoto K. Iwamoto T. Kato S. Miyazono K. 2009 Modulation of microRNA processing by p53 Nature 460 529 533 10.1038/nature08199 19626115
Tay Y. Zhang J. Thomson A.M. Lim B. Rigoutsos I. 2008 MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation Nature 455 1124 1128 10.1038/nature07299 18806776
Vallabhapurapu S. Karin M. 2009 Regulation and function of NF-kappaB transcription factors in the immune system Annu Rev Immunol 27 693 733 10.1146/annurev.immunol.021908.132641 19302050
Van Roosbroeck K. Calin G.A. 2017 Cancer hallmarks and MicroRNAs: the therapeutic connection Adv Cancer Res 135 119 149 10.1016/bs.acr.2017.06.002 28882220
Vazquez-Santillan K. Melendez-Zajgla J. Jimenez-Hernandez L.E. Gaytan-Cervantes J. Munoz-Galindo L. Pina-Sanchez P. Martinez-Ruiz G. Torres J. Garcia-Lopez P. Gonzalez-Torres C. 2016 NF-kappaB-inducing kinase regulates stem cell phenotype in breast cancer Sci Rep 6 37340 10.1038/srep37340 27876836
Vogelstein B. Lane D. Levine A.J. 2000 Surfing the p53 network Nature 408 307 310 10.1038/35042675 11099028
Walker E.J. Zhang C. Castelo-Branco P. Hawkins C. Wilson W. Zhukova N. Alon N. Novokmet A. Baskin B. Ray P. 2012 Monoallelic expression determines oncogenic progression and outcome in benign and malignant brain tumors Cancer Res 72 636 644 10.1158/0008-5472.CAN-11-2266 22144470
Yamada T. Mitani T. Yorita K. Uchida D. Matsushima A. Iwamasa K. Fujita S. Matsumoto M. 2000 Abnormal immune function of hemopoietic cells from alymphoplasia (aly) mice, a natural strain with mutant NF-kappa B-inducing kinase J Immunol 165 804 812 10.4049/jimmunol.165.2.804 10878354
Yamagishi M. Nakano K. Miyake A. Yamochi T. Kagami Y. Tsutsumi A. Matsuda Y. Sato-Otsubo A. Muto S. Utsunomiya A. 2012 Polycomb-mediated loss of miR-31 activates NIK-dependent NF-κB pathway in adult T cell leukemia and other cancers Cancer Cell 21 121 135 10.1016/j.ccr.2011.12.015 22264793
Yamaguchi N. Ito T. Azuma S. Ito E. Honma R. Yanagisawa Y. Nishikawa A. Kawamura M. Imai J. Watanabe S. 2009 Constitutive activation of nuclear factor-kappaB is preferentially involved in the proliferation of basal-like subtype breast cancer cell lines Cancer Sci 100 1668 1674 10.1111/j.1349-7006.2009.01228.x 19538528
Yamamoto M. Ito T. Shimizu T. Ishida T. Semba K. Watanabe S. Yamaguchi N. Inoue J. 2010 Epigenetic alteration of the NF-κB-inducing kinase (NIK) gene is involved in enhanced NIK expression in basal-like breast cancer Cancer Sci 101 2391 2397 10.1111/j.1349-7006.2010.01685.x 20735436
Yu X. Riley T. Levine A.J. 2009 The regulation of the endosomal compartment by p53 the tumor suppressor gene FEBS J 276 2201 2212 10.1111/j.1742-4658.2009.06949.x 19302216
Zhang Q. Lenardo M.J. Baltimore D. 2017 30 years of NF-κB: a blossoming of relevance to human pathobiology Cell 168 37 57 10.1016/j.cell.2016.12.012 28086098
Zhang S. Shan C. Kong G. Du Y. Ye L. Zhang X. 2012 MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK) Oncogene 31 3607 3620 10.1038/onc.2011.523 22105365
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.